The relationship between mean arterial pressure and terlipressin in hepatorenal syndrome-acute kidney injury reversal: A post hoc analysis
These data highlight that terlipressin leads to an early, sustained increase in MAP, which is a key pharmacodynamic target for HRS-AKI reversal.
Authors
- Giuseppe Cullaro (ORCID: https://orcid.org/0000-0002-2935-0245)
- Andrew S. Allegretti (ORCID: https://orcid.org/0000-0001-9416-6623)
- Khurram Jamil (ORCID: https://orcid.org/0000-0001-9155-3513)
- Kavish Rohit Patidar (ORCID: https://orcid.org/0000-0003-3633-382X)
- Juan Carlos Q. Velez (ORCID: https://orcid.org/0000-0001-9670-1095)
Institutions
- Michael E. DeBakey VA Medical Center (US)
- Ochsner Health System (US)
- The University of Queensland (AU)
- University of California, San Francisco (US)
- Baylor College of Medicine (US)
- Massachusetts General Hospital (US)
- Rodin Therapeutics (United States) (US)
- Mallinckrodt (United States) (US)
- Columbia University (US)
Publication Details
- Journal
- Hepatology
- Published
- 2025-03-07
- DOI
- https://doi.org/10.1097/hep.0000000000001295
- Citations
- 3
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 3.97